Heidi Henson

Chief Financial Officer, Kura Oncology.

Companies

Korsana Biosciences, Inc.Board member Sep 10, 2026 to now¹
Perspective Therapeutics, Inc.Board member Jun 2, 2023 to now²
Caladrius BiosciencesBoard member Sep 16, 2022 to now³
PepGen Inc.Board member May 5, 2022 to now⁴
PARDES BIOSCIENCES, INC.Chief financial officer Dec 27, 2021 to Aug 31, 2023⁵
Kura OncologyChief financial officer Mar 16, 2015 to Jan 26, 2018⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Caladrius Biosciences LSTA85,725 shares⁷$84.0K at $0.98Jan 9, 2026
Perspective Therapeutics, Inc. CATX25,975 shares⁸$56.0K at $2.15Dec 4, 2024
PARDES BIOSCIENCES, INC.0 shares⁹Aug 31, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 9, 2026Granted 30,456 shares of Caladrius Biosciences⁷
Jan 9, 2025Granted 15,789 shares of Caladrius Biosciences¹⁰
Dec 4, 2024Bought 25,975 shares at $3.85 of Perspective Therapeutics, Inc.⁸
Jan 9, 2024Granted 19,480 shares of Caladrius Biosciences¹¹
Aug 31, 2023U 316,753 shares of PARDES BIOSCIENCES, INC.⁹
Jan 9, 2023Granted 20,000 shares of Caladrius Biosciences¹²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKorsana Biosciences, Inc., Board member
2
SEC EDGARPerspective Therapeutics, Inc., Board member
3
SEC EDGARCaladrius Biosciences, Board member
4
SEC EDGARPepGen Inc., Board member
5
SEC EDGARPARDES BIOSCIENCES, INC., Chief financial officer
6
SEC EDGARKura Oncology, Chief financial officer
7
SEC EDGARCaladrius Biosciences shares after the filing of Jan 9, 2026
8
SEC EDGARPerspective Therapeutics, Inc. shares after the filing of Dec 4, 2024
9
SEC EDGARPARDES BIOSCIENCES, INC. shares after the filing of Aug 31, 2023
10
SEC EDGARForm 4 filed Jan 13, 2025
11
SEC EDGARForm 4 filed Jan 11, 2024
12
SEC EDGARForm 4 filed Jan 11, 2023